"Our board-certified dermatologists diagnose and treat the full scope of every single one of our patients individual skin conditions, from the most common to the most rare and complex. We reverse the effects of sun, stress, and life experiences to improve your appearance and confidence. Using the latest technologies and offering the most advanced treatment available, we are here for you."

During the past decade, Dermatology Associates conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 13 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Associates" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Journey Medical Corporation" with 4 trials sponsored, "Cassiopea SpA" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Associates" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Associates" are "Plaque Psoriasis" (6 trials), "Psoriasis" (5 trials), "Hyperhidrosis" (4 trials), "Acne Vulgaris" (2 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Dermatology Associates" in a lesser frequency.

Most popular intervention types in "Dermatology Associates" are "Drug" (19 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Vehicle" (5 trials), "Mirikizumab" (3 trials), "CB-03-01 cream, 1%" (2 trials) and "Ixekizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Associates" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Dermatology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Associates, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".